Literature DB >> 3661507

DNA content in Barrett's esophagus and esophageal malignancy.

M J McKinley1, D R Budman, D Grueneberg, R L Bronzo, G S Weissman, E Kahn.   

Abstract

Barrett's esophagus is a premalignant condition; endoscopic surveillance is often performed to search for early adenocarcinoma of the esophagus. In an attempt to detect early changes of malignancy, we have added the use of flow cytometry to routine endoscopic surveillance procedures. DNA histograms were generated from biopsy samples by utilizing a specific DNA fluorochrome (4',6-diamidino-2-phenylindole) and flow cytometry. Sixty-three samples from patients with esophagitis, Barrett's esophagus, and esophageal malignancy were analyzed. An abnormal DNA histogram (aneuploidy) was detected in 79% of esophageal malignancies. In addition, aneuploidy was detected in seven patients with Barrett's esophagus, two of whom had dysplasia. DNA quantification with flow cytometry may be a useful adjunct in screening patients with Barrett's esophagus for early malignant change.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661507

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

Review 1.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Flow cytometry in Barrett's esophagus. What have we learned so far?

Authors:  H S Garewal; R E Sampliner; M B Fennerty
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

Review 3.  Barrett's oesophagus--to screen or not to screen?

Authors:  M Atkinson
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

4.  Flow cytometry and Barrett's esophagus.

Authors:  R D Herman; M J McKinley; R L Bronzo; G S Weissman; I S Goldman; E Kahn; L Stiel
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

Review 5.  Role of p53 assessment in management of Barrett's esophagus.

Authors:  A K Kubba; N A Poole; A Watson
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

6.  Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma.

Authors:  M V González; M L Artímez; L Rodrigo; C López-Larrea; M J Menéndez; V Alvarez; R Pérez; M F Fresno; M J Pérez; A Sampedro; E Coto
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

Review 7.  Barrett's esophagus: model of neoplastic progression.

Authors:  Stig Ramel
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

8.  Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus.

Authors:  P D James; M Atkinson
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.